早期乳腺癌的辅助性曲妥珠单抗治疗 - Suppr

Suppr

超能文献

Adjuvant trastuzumab in early breast cancer.

作者信息

Mariani G, Gianni L

机构信息

Oncologia Medica 1, Istituto Nazionale Tumori, Milano, Italy.

出版信息

Ann Oncol. 2006 Sep;17 Suppl 10:x54-8. doi: 10.1093/annonc/mdl237.

DOI:10.1093/annonc/mdl237

PMID:17018752

Abstract

摘要

相似文献

Adjuvant trastuzumab in early breast cancer.

Ann Oncol. 2006 Sep;17 Suppl 10:x54-8. doi: 10.1093/annonc/mdl237.

Spotlight on trastuzumab as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer.

BioDrugs. 2010 Jun;24(3):207-9. doi: 10.2165/11204680-000000000-00000.

Her2 and trastuzumab in breast cancer.

Cancer Control. 2001 Jan-Feb;8(1):103-10. doi: 10.1177/107327480100800113.

Adjuvant trastuzumab for breast cancer.

BMJ. 2005 Nov 5;331(7524):1035-6. doi: 10.1136/bmj.331.7524.1035.

Neo(adjuvant) trastuzumab treatment: current perspectives.

Breast Cancer. 2009;16(4):288-94. doi: 10.1007/s12282-009-0131-y. Epub 2009 Jul 17.

Trastuzumab in the adjuvant treatment of breast cancer.

Bratisl Lek Listy. 2007;108(2):100-3.

Monoclonal antibody therapy for breast cancer: herceptin.

Cancer Chemother Biol Response Modif. 2003;21:223-33. doi: 10.1016/s0921-4410(03)21010-3.

[The efficacy of adjuvant trastuzumab is confirmed in certain breast neoplasms].

Rev Med Suisse. 2007 Jan 17;3(94):180.

Trastuzumab in breast cancer.

N Engl J Med. 2006 Feb 9;354(6):640-4; author reply 640-4.

Trastuzumab in breast cancer.

N Engl J Med. 2006 Feb 9;354(6):640-4; author reply 640-4.

引用本文的文献

Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems.

BMC Cancer. 2016 Mar 9;16:200. doi: 10.1186/s12885-016-2232-2.

Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone.

Breast Cancer Res. 2010;12 Suppl 2(Suppl 2):S2. doi: 10.1186/bcr2573. Epub 2010 Oct 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Adjuvant trastuzumab in early breast cancer.

Ann Oncol. 2006 Sep;17 Suppl 10:x54-8. doi: 10.1093/annonc/mdl237.

Spotlight on trastuzumab as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer.

BioDrugs. 2010 Jun;24(3):207-9. doi: 10.2165/11204680-000000000-00000.

Her2 and trastuzumab in breast cancer.

Cancer Control. 2001 Jan-Feb;8(1):103-10. doi: 10.1177/107327480100800113.

Adjuvant trastuzumab for breast cancer.

BMJ. 2005 Nov 5;331(7524):1035-6. doi: 10.1136/bmj.331.7524.1035.

Neo(adjuvant) trastuzumab treatment: current perspectives.

Breast Cancer. 2009;16(4):288-94. doi: 10.1007/s12282-009-0131-y. Epub 2009 Jul 17.

Trastuzumab in the adjuvant treatment of breast cancer.

Bratisl Lek Listy. 2007;108(2):100-3.

Monoclonal antibody therapy for breast cancer: herceptin.

Cancer Chemother Biol Response Modif. 2003;21:223-33. doi: 10.1016/s0921-4410(03)21010-3.

[The efficacy of adjuvant trastuzumab is confirmed in certain breast neoplasms].

Rev Med Suisse. 2007 Jan 17;3(94):180.

Trastuzumab in breast cancer.

N Engl J Med. 2006 Feb 9;354(6):640-4; author reply 640-4.

Trastuzumab in breast cancer.

N Engl J Med. 2006 Feb 9;354(6):640-4; author reply 640-4.

引用本文的文献

Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems.

BMC Cancer. 2016 Mar 9;16:200. doi: 10.1186/s12885-016-2232-2.

Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone.

Breast Cancer Res. 2010;12 Suppl 2(Suppl 2):S2. doi: 10.1186/bcr2573. Epub 2010 Oct 22.